Angiotensin‐converting enzyme inhibitors reduce community‐acquired pneumonia hospitalization and mortality.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 12, p. 890, doi. 10.1002/phar.2739
- By:
- Publication type:
- Article
Works matching IS 02770008 AND DT 2022 AND VI 42 AND IP 12
Results: 7
1
2
Impact of concomitant fluconazole on direct oral anticoagulant bleeding risk.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 12, p. 880, doi. 10.1002/phar.2738
- By:
- Publication type:
- Article
3
A systematic review of direct acting antiviral therapies in hepatitis C virus‐negative liver transplant recipients of hepatitis C‐viremic donors.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 12, p. 905, doi. 10.1002/phar.2742
- By:
- Publication type:
- Article
4
Comparison of catheter‐related bloodstream infection rates in pediatric patients receiving parenteral nutrition with soybean oil‐based intravenous fat emulsion versus a mixed oil fat emulsion.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 12, p. 898, doi. 10.1002/phar.2740
- By:
- Publication type:
- Article
5
Effects of GLP‐1 receptor agonists on cardiovascular outcomes in patients with type 2 diabetes and chronic kidney disease: A systematic review and meta‐analysis.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 12, p. 921, doi. 10.1002/phar.2737
- By:
- Publication type:
- Article
6
PROK2, HRNR, and FIG4 as potential genetic biomarkers of high bleeding propensity in East Asian patients with acute coronary syndrome using ticagrelor.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 12, p. 872, doi. 10.1002/phar.2736
- By:
- Publication type:
- Article
7
Issue Information.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 12, p. 869, doi. 10.1002/phar.2426
- Publication type:
- Article